288
Participants
Start Date
April 30, 2004
Primary Completion Date
August 31, 2007
Study Completion Date
August 31, 2007
Zoledronic Acid
Garvan Institute of Medical Research, Sydney
Repatriation General Hospital, Daw Park
Keogh Institute for Medical Research, Nedlands
Helen Hayes Hospital, West Haverstraw
Radiant Research, Wyomissing
Osteoporosis and Clinical Trials Center, Hagerstown
McGuire VA Medical Center, Richmond
Hampton Roads Center for Clinical Research, Norfolk
United Osteoporosis Center, Gainesville
Radiant Research, Stuart
UC Bone Health and Osteoporosis Center, Cincinnati
Mercy Arthritis and Osteoporosis Center, Des Moines
Northwestern Center for Clinical Research, Chicago
Colorado Center for Bone Research, Lakewood
Catalina Pointe Clinical Research Inc., Tucson
New Mexico Clinical Research and Osteoporosis Center, Albuquerque
Diablo Clinical Research, Walnut Creek
Oregon Health Sciences University, Portland
St. Joseph Hospital, Bangor
Clinical Research Center, Vancouver
QEII HealthSciences Center, Halifax
Charlton Medical Building, Hamilton
Centre De Recherche Clinique De Laval, Laval
Royal Victoria Hospital, Montreal
Groupe de Recherche en Rhumatologie et Maladies Osseuses, Sainte-Foy
Saskatoon Osteoporosis Center, Saskatoon
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY